{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:23Z","timestamp":1787020223122,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13126-8","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:04:49Z","timestamp":1774271089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of rpoB mutations associated with rifampicin resistance in Mycobacterium tuberculosis isolates in Malawi"],"prefix":"10.1186","volume":"26","author":[{"given":"Stewart","family":"Soko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pizga","family":"Kumwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"13126_CR1","volume-title":"Global Tuberculosis Report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global Tuberculosis Report 2023. Geneva: WHO; 2023."},{"issue":"4","key":"13126_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","volume":"5","author":"K Dheda","year":"2017","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G. The epidemiology, pathogenesis, transmission, diagnosis and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291\u2013360.","journal-title":"Lancet Respir Med"},{"key":"13126_CR3","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.tube.2021.102083","volume":"128","author":"G Xu","year":"2021","unstructured":"Xu G, Liu H, Jia X, Wang X, Xu P. Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex. Tuberculosis. 2021;128:102083.","journal-title":"Tuberculosis"},{"key":"13126_CR4","doi-asserted-by":"crossref","unstructured":"Agonafir M, Belay G, Feleke A, Maningi N, Girmachew F, Reta M, Fourie PB. Profile and frequency of mutations conferring drug-resistant tuberculosis in the central, Southeastern and Eastern Ethiopia. Infection and Drug Resistance. 2023 Dec 31:2953\u201361.","DOI":"10.2147\/IDR.S408567"},{"key":"13126_CR5","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.2147\/IDR.S333433","volume":"14","author":"MC Li","year":"2021","unstructured":"Li MC, Lu J, Lu Y, Xiao TY, Liu HC, Lin SQ, Xu D, Li GL, Zhao XQ, Liu ZG, Zhao LL. rpoB mutations and rifampin resistance in Mycobacterium tuberculosis. Infect Drug Resist. 2021;14:4119\u201328.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"13126_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/molecules27030885","volume":"27","author":"A Amusengeri","year":"2022","unstructured":"Amusengeri A, Khan A, Tastan Bishop \u00d6. The structural basis of Mycobacterium tuberculosis rpoB drug-resistant clinical mutations on rifampicin drug binding. Molecules. 2022;27(3):885.","journal-title":"Molecules"},{"key":"13126_CR7","doi-asserted-by":"crossref","unstructured":"Yadav S, Rawal G, Jeyaraman M, Jeyaraman N. Advancements in tuberculosis diagnostics: a comprehensive review of the critical role and future prospects of Xpert MTB\/RIF Ultra technology. Cureus. 2024;16(3).","DOI":"10.7759\/cureus.57311"},{"issue":"1","key":"13126_CR8","doi-asserted-by":"publisher","first-page":"2915018","DOI":"10.1155\/2022\/2915018","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z. The value of GeneXpert MTB\/RIF for detection in tuberculosis: a bibliometrics-based analysis and review. J Anal Methods Chem. 2022;2022(1):2915018.","journal-title":"J Anal Methods Chem"},{"key":"13126_CR9","doi-asserted-by":"crossref","unstructured":"Eddabra R, Neffa M. Mutations associated with rifampicin resistance in Moroccan tuberculosis isolates: a systematic review. Interdiscip Perspect Infect Dis. 2020;5185896.","DOI":"10.1155\/2020\/5185896"},{"key":"13126_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1471-2334-14-481","volume":"14","author":"G Mboowa","year":"2014","unstructured":"Mboowa G, Namaganda C, Ssengooba W. Rifampicin resistance mutations in RRDR of rpoB using Xpert MTB\/RIF in Kampala. BMC Infect Dis. 2014;14:481.","journal-title":"BMC Infect Dis"},{"key":"13126_CR11","unstructured":"Malawi Ministry of Health. National Tuberculosis and Leprosy Control Programme Annual Report 2022. Lilongwe: MoH; 2023."},{"issue":"2","key":"13126_CR12","first-page":"1","volume":"6","author":"IF Hoffman","year":"2017","unstructured":"Hoffman IF, Ketseoglou I, Krysiak R, Scott L, Thengolose I, Stevens W, Stanley C, Nguluwe N, Papathanasopoulos MA, Mpunga J, Hosseinipour M. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi. Afr J Lab Med. 2017;6(2):1\u20137.","journal-title":"Afr J Lab Med"},{"key":"13126_CR13","unstructured":"World Health Organization. WHO operational handbook on tuberculosis. Module 3: Diagnosis \u2013 Rapid diagnostics for tuberculosis detection. 2021."},{"key":"13126_CR14","volume-title":"Xpert\u00ae MTB\/RIF and Xpert\u00ae MTB\/RIF Ultra: Technical Manual","author":"Cepheid","year":"2019","unstructured":"Cepheid. Xpert\u00ae MTB\/RIF and Xpert\u00ae MTB\/RIF Ultra: Technical Manual. Sunnyvale, CA: Cepheid; 2019."},{"issue":"1","key":"13126_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/jgid.jgid_112_24","volume":"17","author":"A Shrivas","year":"2025","unstructured":"Shrivas A, Singh S. Tuberculosis diagnosis and management: recent advances. J Global Infect Dis. 2025;17(1):3\u20139.","journal-title":"J Global Infect Dis"},{"issue":"2","key":"13126_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5588\/ijtld.14.0651","volume":"19","author":"A Van Deun","year":"2015","unstructured":"Van Deun A, Aung KJ, Hossain A, De Rijk P, Gumusboga M, Rigouts L, De Jong BC. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. Int J Tuberc Lung Dis. 2015;19(2):185\u201390.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13126_CR17","doi-asserted-by":"crossref","unstructured":"Kumar K, Kon OM. Diagnosis and treatment of tuberculosis: latest developments and future priorities. Annals Res Hosp. 2017;1(5).","DOI":"10.21037\/arh.2017.08.08"},{"issue":"1","key":"13126_CR18","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.1038\/s41598-023-36432-6","volume":"13","author":"M Kubjane","year":"2023","unstructured":"Kubjane M, Cornell M, Osman M, Boulle A, Johnson LF. Drivers of sex differences in the South African adult tuberculosis incidence and mortality trends, 1990\u20132019. Sci Rep. 2023;13(1):9487.","journal-title":"Sci Rep"},{"key":"13126_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.11604\/pamj.2025.52.21.48521","volume":"52","author":"HG Nondoli","year":"2025","unstructured":"Nondoli HG. Tuberculosis in transit: risk factors in Tanzania\u2019s high-mobility border regions. Pan Afr Med J. 2025;52:21.","journal-title":"Pan Afr Med J"},{"key":"13126_CR20","unstructured":"Saidu IA, Nasir Z, Goni BW. Social determinants of tuberculosis in Sub-Saharan Africa: a systematic review. Global J Med Public Health. 2014;3(4)."},{"issue":"12","key":"13126_CR21","doi-asserted-by":"publisher","first-page":"e0260669","DOI":"10.1371\/journal.pone.0260669","volume":"16","author":"PW Wekunda","year":"2021","unstructured":"Wekunda PW, Aduda DS, Guyah B. Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya. PLoS ONE. 2021;16(12):e0260669.","journal-title":"PLoS ONE"},{"issue":"4","key":"13126_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5430\/cns.v5n4p12","volume":"5","author":"T Endjala","year":"2017","unstructured":"Endjala T, Mohamed S, Ashipala DO. Factors that contribute to treatment defaulting amongst tuberculosis patients in Windhoek District, Namibia. Clin Nurs Stud. 2017;5(4):12.","journal-title":"Clin Nurs Stud"},{"key":"13126_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jgar.2020.02.026","volume":"22","author":"ES Solo","year":"2020","unstructured":"Solo ES, Nakajima C, Kaile T, Bwalya P, Mbulo G, Fukushima Y, Chila S, Kapata N, Shah Y, Suzuki Y. Mutations in rpoB and katG genes and the inhA operon in multidrug-resistant Mycobacterium tuberculosis isolates from Zambia. J global Antimicrob Resist. 2020;22:302\u20137.","journal-title":"J global Antimicrob Resist"},{"key":"13126_CR24","doi-asserted-by":"crossref","unstructured":"Nyombi B. Prevalence and Distribution of Multidrug-Resistant Mutations in Mycobacterium tuberculosis in Tanzania. East Afr Sci. 2019 Jan 1.","DOI":"10.24248\/easci.v1i1.14"},{"issue":"8","key":"13126_CR25","doi-asserted-by":"publisher","first-page":"e0296563","DOI":"10.1371\/journal.pone.0296563","volume":"19","author":"PR Torokaa","year":"2024","unstructured":"Torokaa PR, Majigo MV, Kileo H, Urio L, Mbwana MR, Monah MC, Ntibabara SS, Kimambo J, Seleman P, Franklin C, Balama R. The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB\/RIF assay in Tanzania. PLoS ONE. 2024;19(8):e0296563.","journal-title":"PLoS ONE"},{"issue":"1","key":"13126_CR26","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.4102\/ajlm.v12i1.1975","volume":"12","author":"NR Mvelase","year":"2023","unstructured":"Mvelase NR, Cele LP, Singh R, Naidoo Y, Giandhari J, Wilkinson E, de Oliveira T, Swe-Han KS, Mlisana KP. Consequences of rpoB mutations missed by the GenoType MTBDR plus assay in a programmatic setting in South Africa. Afr J Lab Med. 2023;12(1):1975.","journal-title":"Afr J Lab Med"},{"issue":"12","key":"13126_CR27","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","volume":"18","author":"NA Makhado","year":"2018","unstructured":"Makhado NA, Matabane E, Faccin M, Pin\u00e7on C, Jouet A, Boutachkourt F, Goeminne L, Gaudin C, Maphalala G, Beckert P, Niemann S. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis. 2018;18(12):1350\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13126_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12879-025-12351-x","volume":"26","author":"K Getachew","year":"2026","unstructured":"Getachew K, Seid A, Berhane N. Association of D516V, H526Y, and S531L rpoB gene polymorphisms and risk factors with rifampicin resistance in Mycobacterium tuberculosis isolates from pulmonary TB patients in Northwest Amhara, Ethiopia: cross-sectional study. BMC Infect Dis. 2026;26(1):115.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"13126_CR29","doi-asserted-by":"publisher","first-page":"e0198091","DOI":"10.1371\/journal.pone.0198091","volume":"13","author":"E Kigozi","year":"2018","unstructured":"Kigozi E, Kasule GW, Musisi K, Lukoye D, Kyobe S, Katabazi FA, Wampande EM, Joloba ML, Kateete DP. Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda. PLoS ONE. 2018;13(5):e0198091.","journal-title":"PLoS ONE"},{"key":"13126_CR30","doi-asserted-by":"crossref","unstructured":"Uddin MK, Rahman A, Ather MF, Ahmed T, Rahman SM, Ahmed S, Banu S. Distribution and frequency of rpoB mutations detected by Xpert MTB\/RIF assay among beijing and non-beijing rifampicin resistant Mycobacterium tuberculosis isolates in Bangladesh. Infect Drug Resist. 2020 Mar;10:789\u201397.","DOI":"10.2147\/IDR.S240408"},{"issue":"3","key":"13126_CR31","doi-asserted-by":"publisher","first-page":"030006052199759","DOI":"10.1177\/0300060521997596","volume":"49","author":"MC Zeng","year":"2021","unstructured":"Zeng MC, Jia QJ, Tang LM. rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates from rural areas of Zhejiang, China. J Int Med Res. 2021;49(3):0300060521997596.","journal-title":"J Int Med Res"},{"issue":"4","key":"13126_CR32","first-page":"1151","volume":"37","author":"M Alamgir","year":"2021","unstructured":"Alamgir M, Sajjad M, Baig MS, Noori MY. Mutational Frequencies in Mycobacterial rpoB gene using GeneXpert\/MTB Rif assay in rifampicin resistant patients at a tertiary care setting in Urban Sindh, Pakistan: Analysis from a five-year period. Pakistan J Med Sci. 2021;37(4):1151.","journal-title":"Pakistan J Med Sci"},{"issue":"1","key":"13126_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/pathogens15010016","volume":"15","author":"S Soidah","year":"2025","unstructured":"Soidah S, Subroto T, Faizal I, Yusuf M. Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis. Pathogens. 2025;15(1):16.","journal-title":"Pathogens"},{"issue":"1","key":"13126_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12879-020-05031-5","volume":"20","author":"NK Chisompola","year":"2020","unstructured":"Chisompola NK, Streicher EM, Muchemwa CM, Warren RM, Sampson SL. Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review. BMC Infect Dis. 2020;20(1):344.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13126_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12879-025-10655-6","volume":"25","author":"M Jose Vadakunnel","year":"2025","unstructured":"Jose Vadakunnel M, Nehru VJ, Brammacharry U, Ramachandra V, Palavesam S, Muthukumar A, Mani BR, Pradhabane RSS, Vn G, Subramani AD. Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis. BMC Infect Dis. 2025;25(1):284.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"13126_CR36","doi-asserted-by":"publisher","first-page":"002048","DOI":"10.1099\/jmm.0.002048","volume":"74","author":"K Vallejos-Sanchez","year":"2025","unstructured":"Vallejos-Sanchez K, Taquiri-D\u00edaz DA, Romero-Rodriguez OA, Vargas-Ruiz AP, Coronel J, Torres A, Perez-Martinez JL, Ochoa-Ortiz A, Gilman RH, Grandjean L, Cohen-Gonsaud M. Dissecting rifampicin heteroresistance in Mycobacterium tuberculosis: integrating whole-genome sequencing with phenotypic and clonal validation. J Med Microbiol. 2025;74(7):002048.","journal-title":"J Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13126-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:41:23Z","timestamp":1777588883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13126-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13126"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13126-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Mzuzu University Faculty of Health Sciences Ethics Review Committee (Ethical Clearance Number FOHS\/REC\/23\/174). Authorities from Queen Elizabeth Central Hospital, DREAM Blantyre Clinic, Zingwangwa Health Centre, Limbe Health Centre, and Ndirande Health Centre granted permission to conduct the study at their facilities. Consent to participate was not obtained because the study only involved the review of patient records, and the requirement was therefore waived by the Mzuzu University Faculty of Health Sciences Ethics Review Committee (Ethical Clearance No. FOHS\/REC\/23\/174). Nevertheless, the patient\u2019s data was anonymized through the use of serial numbers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"865"}}